Intestinal lipid processing machinery

The intestinal lipid processing machinery refers to a complex integrated system of transporters and enzymes within enterocytes responsible for the uptake, re-esterification, and packaging of dietary lipids into chylomicrons (Mansbach & Siddiqi, 2010, PubMed). Key molecular components include Niemann-Pick C1-like 1 (NPC1L1) for cholesterol absorption, Cluster of Differentiation 36 (CD36) for fatty acid uptake, and Microsomal Triglyceride Transfer Protein (MTP) for the assembly of apolipoprotein B-48 containing lipoproteins (Altmann et al., 2004, Science; Cuchel et al., 2013, The Lancet). This machinery is a critical determinant of postprandial lipid levels and systemic cholesterol homeostasis. Pharmacological targeting of this system is a primary strategy for treating dyslipidemia and reducing cardiovascular risk. For example, ezetimibe inhibits NPC1L1 to lower LDL cholesterol, while lomitapide inhibits MTP to treat homozygous familial hypercholesterolemia (StatPearls, 2023; FDA Label). However, because this machinery is essential for nutrient absorption, its inhibition can lead to gastrointestinal side effects and potential deficiencies in fat-soluble vitamins (Hussain et al., 2012, Journal of Lipid Research).

Other names

Intestinal lipid absorption pathwayChylomicron assembly machineryEnterocyte lipid metabolism systemDietary lipid processing

Inhibition of specific transporters such as NPC1L1 to block cholesterol uptake, or inhibition of enzymes like MTP and DGAT1 to prevent the assembly and secretion of triglyceride-rich chylomicrons into the lymphatic system.